SanBio Company Limited
SanBio Company Limited Expands Commitment Line with Resona Bank, Increasing Borrowing Facility to 5,000 million yen
To meet working capital needs associated with domestic sales of Akougo®, SanBio expanded its commitment line with Resona Bank and increased the borrowing facility to 5,000 million yen. The previous 1,000 million yen facility terminated on the same date. The impact on consolidated earnings guidance for the fiscal year ending January 2027 is minimal.
Key Figures
- Key Figure 1: Commitment Line Amount 5,000 million yen
- Key Figure 2: Agreement Term October 30, 2028
- Key Figure 3: Previous facility of 1,000 million yen terminated as of the execution date of this agreement
AI要約
Overview of Capital Policy
SanBio refreshed its existing commitment line with Resona Bank and expanded the borrowing facility to 5,000 million yen. The new agreement aims to secure working capital related to the domestic sales of Akougo®, allowing funds previously raised through equity issuance to be redirected to growth investments, thereby strengthening the financial base and increasing funding flexibility. The previous 1,000 million yen facility terminated as of the execution date of this agreement.
Outlook and Impact
The impact on consolidated earnings guidance for the fiscal year ending January 2027 is considered minimal, and the arrangement improves funding stability to support business development and scale-up following the launch of Akougo® sales. The company will continue to expand its business through regional deployment and both manufacturing and sales operations.
SanBio Company Limited
Company overview · Stock price · Financial data · All IR
